Hong Kong Two-Way Gateway
With Hong Kong as the Connecting Point,
Linking Mainland China and Global Markets
Hong Kong is both NovoBay's base and current priority market, as well as an important gateway connecting Mainland China and global partnerships. Drawing on experience in healthcare, law, capital markets and biotechnology, the team helps companies understand the practical conditions for cross-regional collaboration.
International CompaniesUse Hong Kong as a Starting Point for Mainland China
Help multinational diagnostics and pharmaceutical companies understand the market, clinical and partnership ecosystems in Hong Kong and Mainland Greater Bay Area cities, and assess phased routes forward.
Mainland Chinese CompaniesUse Hong Kong as a Gateway to Global Partnerships
Connect Hong Kong's international professional services, clinical research and industry networks to help Mainland Chinese companies assess overseas partnership opportunities and implementation requirements.